CDKN2A and atherosclerosis: In older (23 months old [m.o.]) ApoE–/– mice, which are genetically modified mice often used to study atherosclerosis, the expression levels of both the senescent markers p16 and DPP4 increased in the plaque area compared with those of control mice (Figure 1H and Supplemental Figure 1I).